Long-Term Persistence of Hormonal Adaptations to Weight Loss
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Background After weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss. Methods We enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite. Results Weight loss (mean [±SE], 13.5±0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P Conclusions One year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hormonal and metabolic changes induced by weight reduction result in elevated appetite and reduced metabolic rate [13][14][15].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [13]
In the citing paper
“Weight loss is accompanied by persistent endocrine adaptations30 that increase appetite and decrease satiety31 thereby resisting continued weight loss and conspiring against long-term weight maintenance.”
From Maintenance of Lost Weight and Long-Term Management of Obesity (2018) · cites this paper as [30]
In the citing paper
“studies have shown that the pandemic was associated with weight gain in the general population. 25”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [25]
In the citing paper
“and to increased appetite. 9-11”
From Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (2021) · cites this paper as [10]
In the citing paper
“although only 2% of eligible patients are currently receiving therapy [17].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [17]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
Changes in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012
Cited by
Items 801–900 of 1,004
Cutting-Edge Approaches to Obesity Management: The Latest Pharmacological Options
Schmitz, S. H., Saunders, K. H., & Aronne, L. J. (2025) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.09.003 · Cited by 12
Liraglutide—another weapon in the war against obesity?
Bray, G. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.133 · Cited by 10
Higher postprandial serum ghrelin among African-American girls before puberty
Ellis, A. C., Casazza, K., Chandler-Laney, P. C., & Gower, B. A. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0081 · Cited by 12
“Because ghrelin regulation may relate to propensity for obesity and weight regain (4) , this study was designed to characterize age group differences in total serum ghrelin among a cohort of AfricanAmerican females, an understudied group with a high rate of obesity (24, 25) .”
BackgroundHill, B. R., Souza, M. J. D., Wagstaff, D. A., & Williams, N. I. (2013) · Peptides · doi:10.1016/j.peptides.2013.08.018 · Cited by 10
“Several studies have reported varying results of fasting or changes in single meal-related responses in postprandial PYY subsequent to weight loss [16, 21, 33, 38].”
BackgroundResultMogul, H. R., Freeman, R., Nguyen, K., Frey, M., Klein, L.-A., Jozak, S., & Tanenbaum, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108264 · Cited by 12
“Maintenance of leptin despite weight loss was thoroughly unexpected, in view of the well documented central role of leptin decline as a primary mediator of weight regain in body weight regulation [52,53].”
BackgroundControl of Body Weight by Eating Behavior in Children
Zandian, M., Bergh, C. E. K., Ioakimidis, I., Esfandiari, M., Hamilton-Shield, J. P., Lightman, S. L., Leon, M., & Södersten, P. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00089 · Cited by 11
“Relapse into obesity, which is all too common, is hypothetically caused by irreversible biological changes, such as elevated levels of ghrelin, a purported hunger hormone (11, 77).”
Losing It: The Construction and Stigmatization of Obesity on Reality Television in the United States
Roost, A. C. (2016) · The Journal of Popular Culture · doi:10.1111/jpcu.12377 · Cited by 12
Kleinendorst, L., van Haelst, M. M., & van den Akker, E. L. T. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_19 · Cited by 15
Ryan, D. H., Barquera, S., Cavalcanti, O. B., & Ralston, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-05325-3_39-1 · Cited by 15
Abdalgwad, R., Rafey, M. F., Foy, S., Newell, M., Davenport, C., O'Keeffe, D. T., & Finucane, F. M. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.551068 · Cited by 16
“In humans, very low calorie diet- induced weight loss leads to alterations in gut hormones that promote hunger and decrease satiety, ultimately driving weight regain (26, 27).”
BackgroundWeight Regain and Insufficient Weight Loss after Bariatric Surgery: A Call for Action
Elhag, W., & Ansari, W. E. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94848 · Cited by 10
“Whilst hormonal adaptation as a biological response to non-surgical WL has been examined [31], its influence on WR post BS is less documented in humans.”
BackgroundLaughlin, M. R., Osganian, S. K., Yanovski, S. Z., & Lynch, C. J. (2021) · Obesity · doi:10.1002/oby.23079 · Cited by 12
Watkins, S., Toliver, J. C., Kim, N., Whitmire, S., & Garvey, W. T. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.22116 · Cited by 10
A new era in gut hormone-based pharmacotherapy for people with obesity
Firman, C., & Batterham, R. L. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122002695 · Cited by 10
“…increase in the circulating levels of orexigenic hormone ghrelin, a reduction in satiety hormones (peptide YY and glucagon-like peptide-1) and adiposity signals such as leptin and insulin (29-31) and enhanced brain response to high-energy food cues in homeostatic and reward brain region (32, 33) .”
BackgroundKhalifa, O., Mroué, K. H., Mall, R., Ullah, E., Al-Akl, N. S., & Arredouani, A. (2022) · Biomedicines · doi:10.3390/biomedicines10102652 · Cited by 10
“Unfortunately, losing the amount of weight required to improve NAFLD has been proven to be difficult, and maintaining that weight loss has been proven to be even more difficult [10,11].”
BackgroundCicuttini, F., Proietto, J., & Lim, Y. Z. (2023) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2023.100407 · Cited by 11
“…controlling hormones such as leptin, cholecystokinin and GLP-1 change in a direction to make the individual more hungry [26 – 28], as shown in Table 1 and there is a reduction in energy expenditure [29], changes that are long lasting, still present at 6 years [30,31] to account for weight regain.”
BackgroundSelf-citationBrevers, D., Rogiers, A., Defontaine, A., Chéron, G., Clarinval, A.-M., Foucart, J., Bouchez, A., Bolly, V., Tsartsafloudakis, L., Jottrand, P., et al. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00243 · Cited by 15
Flechtner‐Mors, M., Thoma, U., Wittmann, R., Boehm, B. O., Mors, M., Steinacker, J. M., & Schümann, U. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s201853 · Cited by 11
“The GLP-1 release in our study was lower at test meal 2, a finding consistent with previous studies which reported a significant decrease in GLP-1 concentration after 62 weeks of diet, which was less pronounced after 10 weeks.(29) The weight reduction in our study resulted in higher overall ghrelin concentrations.”
BackgroundResultThom, G., Lean, M. E. J., Brosnahan, N., Algindan, Y., Malkova, D., & Dombrowski, S. U. (2020) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12826 · Cited by 10
“Weight loss is considered to alter hunger and satiety pathways in a direction favouring positive energy balance ((41)), although, in a separate mixed-methods analysis of the data generated as part of the present study, stress rather than hunger was perceived as the factor most likely to trigger eating/weight regain du…”
ResultObesity, metabolic syndrome, and disorders of energy balance
Weiss, R., & Lustig, R. H. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00031-7 · Cited by 14
Truby, H., Bennett, C., & Martins, C. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120007028 · Cited by 11
“In adults, it is well established that diet-induced weight loss is accompanied by several physiological changes on both sides of the energy balance equation, with an upregulation of appetite which stimulates energy intake((51,66)), despite a reduced TEE((67)).”
Brown, A., Mellor, D., Makaronidis, J., Shuttlewood, E., Miras, A. D., & Pournaras, D. J. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12700 · Cited by 9
Haggerty, T. S., Dekeseredy, P., Bailey, J., Cowher, A. E., Baus, A., & Davisson, L. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100120 · Cited by 13
“Additionally, as patients regain all or some of the weight they lost while on these medications, there are concerns that their metabolism may not recover to its previous level, as seen in studies of considerable weight loss [25].”
BackgroundDanielak, A., & Magierowski, M. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107741 · Cited by 9
García-Gorrita, C., Onofre, N. S., Merino-Torres, J. F., & Soriano, J. M. (2025) · Nutrients · doi:10.3390/nu17162699 · Cited by 10
Obesity and Weight Management in HIV: Epidemiology, Complications, and Emerging Treatments
Pryke, L. A., Koethe, J. R., & Bailin, S. S. (2026) · Current HIV/AIDS Reports · doi:10.1007/s11904-026-00776-1 · Cited by 13
“Additionally, these hormonal adaptations to weight loss can persist, well beyond the initial caloric restriction period [72].”
Fu, S., Chen, J., & Wang, X. C. (2026) · Nutrients · doi:10.3390/nu18111830 · Cited by 10
“In addition, short-term energy surplus may disrupt the dynamic balance of appetite-regulating hormones [47], and strengthen the emotion–eating link via the reward system, thereby increasing the risk of subsequent eating instability and repeated excessive intake [48].”
The ‘Behavioral Balance Model’: A new perspective on the aetiology and therapy of obesity
Schultes, B., Ernst, B., Hallschmid, M., Bueter, M., & Meyhöfer, S. M. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15271 · Cited by 10
“13 Together, these counterregulatory responses are thought to provoke a progressive weight regain that is often perceived as a frustrating yo-yo effect by individuals who attempt to lose weight.”
BackgroundEmini, M., Bhargava, R., Aldhwayan, M., Chhina, N., Rodríguez-Flores, M., Aldubaikhi, G., Lababidi, M. A., Al‐Najim, W., Miras, A. D., Ruban, A., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae214 · Cited by 9
Obesity consults—comprehensive obesity management in 2013: Understanding the shifting paradigm
Kushner, R. F., Apovian, C. M., & Fujioka, K. (2013) · Obesity · doi:10.1002/oby.20627 · Cited by 14
“The body reacts to cutting calories by lowering the metabolic rate and adjusting numerous hormones to retain weight, particularly those hormones that signal satiety (33).”
BackgroundMiguet, M., Beaulieu, K., Fillon, A., Khammassi, M., Masurier, J., Lambert, C., Duclos, M., Boirie, Y., Finlayson, G., & Thivel, D. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112996 · Cited by 9
Habibi, N., Leemaqz, S., & Grieger, J. A. (2022) · Nutrients · doi:10.3390/nu14071518 · Cited by 10
“However, it is evident that the practicality of reducing energy intake is rarely achieved over the longer term [49], and continuous energy restriction may be problematic, partly due to increases in the desire to eat [50], feelings of hunger [51], and cravings [52].”
BackgroundThe influence of resistance training on adipokines in post-menopausal women: A brief review
Chapman-Lopez, T. J., Wilburn, D. T., Fletcher, E., Adair, K. E., Ismaeel, A., Heileson, J. L., Gallucci, A. R., Funderburk, L., Koutakis, P., & Forsse, J. S. (2022) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2022.09.001 · Cited by 10
Price, S., & Sumithran, P. (2022) · Nutrients · doi:10.3390/nu14204423 · Cited by 9
“Subjective appetite ratings were also lower during ketosis [38,58].”
BackgroundSelf-citationBrethvad, A. O., Zakariassen, H. L., Holt, J., Lundgren, J. R., Jakobsen, A., Hartmann, B., Lehmann, E. W., Kissow, H., Holst, J. J., Madsbad, S., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155534 · Cited by 11
Endo, S., Uto, A., Miyashita, K., Sato, M., Inoue, H., Fujii, K., Hagiwara, A., Ryuzaki, M., Oshida, T., Kinouchi, K., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad082 · Cited by 9
“In the case of CR, even if an obese individual exhibited weight loss once, regaining of the lost weight within a short period after discontinuation maybe a problem [29].”
BackgroundIdentification of adipose tissue transcriptomic memory of anorexia nervosa
Zapata, R. C., Nasamran, C. A., Chilin-Fuentes, D., Dulawa, S. C., & Osborn, O. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00705-7 · Cited by 9
“2003, 2005) and appetite regulation (Sumithran et al. 2011; Doucet et al. 2000), which encourage weight re-gain.”
BackgroundImpact of Medical and Surgical Obesity Treatment on Dental Caries: A 2-Year Prospective Cohort Study
Taghat, N., Mossberg, K., Lingström, P., Petzold, M., & Östberg, A. (2023) · Caries Research · doi:10.1159/000533609 · Cited by 10
“It might be hypothesized that the intestinal differences in anatomy after RYGB and SG could have an impact, for example, on nutritional and hormonal status with subsequent consequences [Sumithran et al., 2011; Höskuldsdottir et al., 2022].”
BackgroundObesity Bias, Medical Technology, and the Hormonal Hypothesis: Should We Stop Demonizing Fat People?
deShazo, R. D., Hall, J. E., & Skipworth, L. B. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.11.024 · Cited by 13
Fujioka, K., Sparre, T., Sun, L. Y.-H., Krogsgaard, S. M., & Kushner, R. F. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815593295 · Cited by 10
“However, achieving and maintaining weight loss by diet and physical activity alone can be challenging.(10-12) Pharmacotherapy supports weight loss and 593295 DSTXXX10.”
BackgroundGadela, N. V., Umashanker, D., Scatola, A., & Jaiswal, A. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-020-00500-z · Cited by 9
When behaviour meets biology: if obesity is a chronic medical disease what is obesity management?
Vallis, M., & Macklin, D. (2021) · Clinical Obesity · doi:10.1111/cob.12443 · Cited by 9
Simple Energy Balance or Microbiome for Childhood Obesity Prevention?
Baranowski, T., & Motil, K. J. (2021) · Nutrients · doi:10.3390/nu13082730 · Cited by 9
“, hormones [20,21], influence the energy available and energy expenditure beyond simple dietary energy intake and expenditure.”
BackgroundCaloric Restriction to Moderate Senescence: Mechanisms and Clinical Utility
Anton, S. D., Karabetian, C., Heekin, K., & Leeuwenburgh, C. (2013) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-013-0062-5 · Cited by 9
“These neuroendocrine signals that occur during calorie restriction and following weight loss persist with prolonged weight reduction [75, 76].”
BackgroundRoles of calcium and Mitochondria-Associated Membranes in the development of obesity and diabetes
Cárdenas-Pérez, R. E., & Camacho‐Morales, A. (2016) · Medicina Universitaria · doi:10.1016/j.rmu.2015.10.004 · Cited by 10
Poghosyan, V., Ioannou, S., Al-Amri, K. M., Al-Mashhadi, S. A., Al-Mohammed, F., Al-Otaibi, T., & Al-Saeed, W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.948063 · Cited by 8
“Negative energy balance induced by lifestyle intervention triggers hormonal response that aims to maintain the higher body weight (Klok et al., 2007; Sumithran et al., 2011).”
BackgroundA Survey of Obesity Education and Training in United States Pharmacy Schools
Phillips, E. J., Traina, A. N., & Smolarz, B. G. (2023) · American Journal of Pharmaceutical Education · doi:10.1016/j.ajpe.2023.100109 · Cited by 10
“6 15 In combination with a reduced-calorie diet and increased physical activity, pharmacotherapy (or anti-obesity medications [AOMs]), can be effective in managing obesity 16–18 and is recommended by treatment guidelines.”
BackgroundBreit, M. J., Caldwell, A. E., Ostendorf, D. M., Pan, Z., Creasy, S. A., Swanson, B., Clark, K., Hill, E. B., MacLean, P. S., Bessesen, D. H., et al. (2025) · Nutrients · doi:10.3390/nu17142385 · Cited by 9
“However, consistent with physiological adaptations to weight loss, fasting leptin decreased, and ghrelin increased in both groups, reflecting known endocrine responses to negative energy balance [4].”
Obesity Medication Treatment Perspectives Among People with Overweight or Obesity
Ostrominski, J. W., Chhibber, A., Kuti, E. L., Clark, B. J., & Donato, B. M. K. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s555622 · Cited by 8
GOETZ, I. A., Kanu, C., Hoover, A., Jimenez‐Moreno, C., Karn, H., Kimel, M., Neff, L. M., & Boye, K. S. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100220 · Cited by 9
“However, weight loss can trigger adaptive changes in hunger and satiety hormones which persist over time and favor weight regain, making long-term maintenance of weight reduction more challenging [19].”
Mirošević, G., Nikolić, M., Kruljac, I., Ljubičić, N., Bekavac‐Beslin, M., Milošević, M., Pezo-Nikolić, B., Supanc, V., Budimir, I., & Vrkljan, M. (2013) · Endocrine · doi:10.1007/s12020-013-0069-x · Cited by 8
Campos, J. M., RAMOS, A. C., SZEGO, T., Zilberstein, B., Neto, H. F. E. C., & COHEN, R. V. (2016) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-67202016nahead0001 · Cited by 16
Emerging insights in weight management and prevention: implications for practice and research
Doucet, É., Hall, K. D., Miller, A., Taylor, V. H., Ricupero, M., Haines, J., Brauer, P. M., Gudzune, K. A., House, J. D., & Dhaliwal, R. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0585 · Cited by 8
“In response to sustained energy restriction leading to weight loss, signals that reduce appetite are downregulated (Sumithran et al. 2011), while the appetite stimulant peptide ghrelin is upregulated (Cummings et al.”
BackgroundLim, J. Z. M., Alam, U., Cuthbertson, D. J., & Wilding, J. P. H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044519 · Cited by 8
Kuckuck, S., van der Valk, E. S., Scheurink, A. J. W., Lengton, R., Mohseni, M., Visser, J. A., Iyer, A. M., van den Berg, S. A. A., & van Rossum, E. F. C. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1010858 · Cited by 9
“Reductions in anorexigenic leptin and insulin levels may be interpreted as potentially hunger-inducing (Sumithran et al., 2011; Sumithran and Proietto, 2013).”
BackgroundResultInfluentialWeight loss to disrupt type 2 diabetes
Alsaqaaby, M. S., & le Roux, C. W. (2023) · Diabetology International · doi:10.1007/s13340-023-00626-0 · Cited by 8
“Although substantial weight loss can be achieved with lifestyle interventions, weight loss maintenance remains a challenge [32].”
BackgroundApproach to the Patient: Navigating Body Mass Index Requirements for Gender-Affirming Surgery
Taormina, J. M., Kissee, M. C., Brownstone, L. M., Grimstad, F. W., Morrison, S. D., Hendrixson, A., & Iwamoto, S. J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae193 · Cited by 8
MCRAE, A. N., Ticho, A. L., Liu, Y., Ricardo-Silgado, M. L., Mangena, N. N., Feris, F., Gonzalez‐Izundegui, D., Calderón, G., Rohakhtar, F. R., Simon, V. A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105283 · Cited by 8
Obesity Drug Outcome Measures: Results of a Multi-Stakeholder Critical Dialogue
Kahan, S. I., Ferguson, C. C., David, S., & Divine, L. (2013) · Current Obesity Reports · doi:10.1007/s13679-013-0052-0 · Cited by 8
Bhagat, K., & Howard, D. E. (2018) · Qualitative Health Research · doi:10.1177/1049732318764396 · Cited by 8
Thackray, A. E., Willis, S. A., Clayton, D. J., Broom, D. R., Finlayson, G., Goltz, F. R., Sargeant, J. A., Woods, R. M., Stensel, D. J., & King, J. A. (2020) · Nutrients · doi:10.3390/nu12092635 · Cited by 8
“This work has shown that diet-induced energy deficits produce rapid compensatory appetite responses [5,6] that endure whilst energy stores remain depleted [7].”
BackgroundGolden, A. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-48683-9_4 · Cited by 8
Perceptions of obesity pharmacotherapy by nurse practitioners
Bottcher, K., & Chao, A. M. (2021) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000678 · Cited by 8
“For example, 86% of those with type-2 diabetes mellitus are prescribed medication (Thomas et al., 2016).”
BackgroundChiu, M., MOIST, L. M., Al‐Jaishi, A. A., & Jain, A. K. (2022) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581221129465 · Cited by 9
Clinical Practice Guideline for the Management of Overweight and Obesity in Adults in Saudi Arabia
Alshaikh, A., Al-Jedai, A. H., Alfadda, A. A., Al-Robayan, A. A., Bawahab, A., Abo’ouf, S., Sultan, A., Alhozali, A. M., Bawazeer, M. A., Sheshah, E., et al. (2022) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2022.1312045 · Cited by 9
Brenton-Peters, J., Consedine, N. S., Cavadino, A., Roy, R., Ginsberg, K. H., & Serlachius, A. S. (2023) · British Journal of Health Psychology · doi:10.1111/bjhp.12686 · Cited by 8
Brain Reorganization following Weight Loss
Rosenbaum, M., & Leibel, R. L. (2012) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000341282 · Cited by 8
Edshteyn, I., Uduhiri, K. A., Morgan, T. O., Rhodes, K., & Sherin, K. M. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.05.010 · Cited by 8
Heymsfield, S. B., Bourgeois, B. L., & Thomas, D. M. (2017) · Obesity · doi:10.1002/oby.22045 · Cited by 10
“Long-term studies of up to 1 year have provided evidence that lifestyle treatments are accompanied by metabolic adaptations with reductions in resting energy expenditure (3) and persistent changes in hormonal mediators of appetite (4), which underlie and partially account for reducing the magnitude of weight loss over…”
BackgroundBeeken, R. J., Mahdi, S., Johnson, F., & Meisel, S. F. (2018) · Obesity Facts · doi:10.1159/000486961 · Cited by 8
Luo, Y., Zhang, X., Tsauo, J., Jung, H., Song, H.-Y., Zhao, H., Li, J., Gong, T., Song, P., & Li, X. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07467-x · Cited by 8
Campanella, A., Sorino, P., Bonfiglio, C., Mirizzi, A., Franco, I., Bianco, A., Misciagna, G., Caruso, M. G., Cisternino, A. M., Notarnicola, M., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00954-8 · Cited by 9
“Moreover changes in signals from the gastrointestinal system after dietinduced weight loss are thought to be important for weight regain [11, 12], but studies on direct associations with weight regain are lacking.”
BackgroundOvereating makes the gut grow fonder; new insights in gastrointestinal satiety signaling in obesity
Maljaars, J. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835d9fe0 · Cited by 11
CD1 is involved in diet-induced hypothalamic inflammation in obesity
Bombassaro, B., Ramalho, A. F. S., Fioravante, M., Solon, C., Nogueira, G. A. S., Nogueira, P. A. S., Gaspar, R. S., Ropelle, E. R., & Velloso, L. A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.011 · Cited by 8
Torensma, B., Hany, M., Aarts, E. O., Berends, F. J., van Wagensveld, B. A., Parmar, C. D., Shikora, S. A., & COHEN, R. V. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07870-0 · Cited by 9
Effect of vagus nerve stimulation on metabolism: a systematic review and meta-analysis
Shen, T., Tang, X., Pan, Y., He, H., & Hu, K. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01871-w · Cited by 8
“Research has shown that reduced calorie intake may be counteracted by metabolic adaptation [7], where a reduction in resting metabolic rate and an increase in appetite [8] may offset or even negate the efforts to lose weight.”
Park, C., Kim, Y., Raygani, S., & Grunvald, E. L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1630199 · Cited by 7
“A negative energy balance lowers metabolic rate and intensi fi es hunger and cravings (23, 24).”
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies
Rejili, M. S., Hussain, M. S., Khan, Y., Haouala, F., Ganesan, S., Sahoo, S., Pal, A., & Arora, V. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107563 · Cited by 7
Tronieri, J. S., Allison, K. C., DeRouen, K., Amaro, A., Collins, K. G., Roy, A., Watts, S., Ananna, T., & Wadden, T. A. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101403 · Cited by 11
“Large short-term weight losses have been shown to produce long-term compensatory changes in appetite-regulating hormones and increases in subjective appetite that likely promote weight regain [6].”
Vincenzo, A. D., Crescenzi, M., Granzotto, M., Zancaner, S., Fabris, R., D, M. F. M., Prevedello, L., Capone, F., Vettor, R., & Rossato, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113752 · Cited by 7
Zhao, X., Wang, Y., Li, X., Hu, P., Pan, X., He, B., Liu, Y., Hu, Y., & Zhu, T. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s484565 · Cited by 8
Metabolic Consequences of Weight Reduction
Rosenbaum, M. (2012) · Wiley eBooks · doi:10.1002/9781394323142.ch20 · Cited by 7
What are the challenges in developing effective health policies for obesity?
Binks, M., & Chin, S.-H. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.1 · Cited by 7
Long‐term weight loss maintenance in obesity: Possible insights from anorexia nervosa?
Gianini, L. M., Walsh, B. T., STEINGLASS, J. E., & Mayer, L. (2017) · International Journal of Eating Disorders · doi:10.1002/eat.22685 · Cited by 7
“Both groups have significantly lower resting energy expenditure, lower levels of leptin and thyroid hormone, and higher levels of ghrelin than BMI-matched controls (Rosenbaum, Hirsch, Gallagher, & Leibel, 2008; Sumithran et al., 2011).”
BackgroundWeight Loss: How Does It Fit in With Liposuction?
Davis, W., & Lawrence, N. (2019) · Dermatologic Surgery · doi:10.1097/dss.0000000000002225 · Cited by 8
“An increase in subjective hunger persists for over a year after dietary interventions, along with alterations in endocrine activity, with satiety hormones depressed and hunger hormones elevated.(11)”
BackgroundGuess, N. D. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01220-4 · Cited by 7
Physiology of the Weight-Reduced State and Its Impact on Weight Regain
Hafida, S., & Apovian, C. M. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.06.002 · Cited by 8
Tolvanen, L., Christenson, A., Eke, H., Bonn, S. E., & Lagerros, Y. T. (2023) · Obesity Facts · doi:10.1159/000529267 · Cited by 7
Spranger, L., Weiner, J. M., Bredow, J., Zeitz, U., Grittner, U., Boschmann, M., Dickmann, S., Stobäus, N., von Schwartzenberg, R. J., Brachs, M., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.02.020 · Cited by 8
Phipps, D., & Helton, M. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-29171-5_2 · Cited by 12
Advancements in the management of obesity: a review of current evidence and emerging therapies
Abdalla, M. A., Ssemmondo, E., Mark‐Wagstaff, C., & Sathyapalan, T. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2347258 · Cited by 10
Hypothalamic Inflammation: Is There Evidence for Human Obesity?
Kumar, R. B., & Aronne, L. J. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0104-0 · Cited by 8
Endocrine-Disrupting Chemicals and Human Disease∗
Heindel, J. J., & Zoeller, R. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00153-0 · Cited by 7
Handboek leefstijlgeneeskunde: De basis voor iedere praktijk
Halberstadt, J., van Rossum, L., Seidell, J. C., de Vries, M., & de Weijer, T. (2020) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2324-1 · Cited by 8
Energy Balance and Weight Loss for Diabetes Remission
Ryan, D. H. (2020) · Diabetes Spectrum · doi:10.2337/ds20-0005 · Cited by 8
Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
Петерс (2021) · The Journal of Family Practice · doi:10.12788/jfp.0223 · Cited by 11
Primary Prevention of CVD with Aspirin: Benefits vs Risks
Weisman (2021) · The Journal of Family Practice · doi:10.12788/jfp.0222 · Cited by 9
Cardiorenal outcomes in eligible patients referred for bariatric surgery
Dash, S., Everett, K., Jackson, T. D., Okrainec, A., Urbach, D. R., Sockalingam, S., Shah, B. R., & Farkouh, M. E. (2021) · Obesity · doi:10.1002/oby.23294 · Cited by 7
The role of weight control in the management of type 2 diabetes mellitus: Bariatric surgery
Xu, T. Q., & Kindel, T. L. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110667 · Cited by 9
Obesity, Liberty, and Public Health Emergencies
Herington, J., Dawson, A., & Draper, H. (2014) · The Hastings Center Report · doi:10.1002/hast.350 · Cited by 12
Metadata
- Authors
- Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J.
- Affiliations
- The University of Melbourne (AU)
- La Trobe University (AU)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-10-27
- Volume
- 365
- Issue
- 17
- Pages
- 1597-1604
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2167222546
- Semantic Scholar
- 3a76a35458f699a743f3d47b276f2fea2ca1d1c0
- Cited by
- 1,449
- References
- 39
- Citations by year
- 2026: 128 · 2025: 98 · 2024: 97 · 2023: 99 · 2022: 104 · 2021: 109 · 2020: 104 · 2019: 92 · 2018: 101 · 2017: 101 · 2016: 86 · 2015: 79 · 2014: 78 · 2013: 95 · 2012: 75
- FWCI
- 37.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- weight loss, hormonal adaptation, appetite, leptin, ghrelin, peptide YY, cholecystokinin, glucose-dependent insulinotropic polypeptide, pancreatic polypeptide, amylin, glucagon-like peptide-1, insulin, very low calorie diet, weight regain
- MeSH terms
- Body Weight, Cholecystokinin, Diet, Reducing, Female, Gastrointestinal Hormones, Humans, Male, Middle Aged, Obesity, Peptides, Weight Loss, Body Mass Index, Postmenopause, Peptide YY, Leptin, Glucagon-Like Peptide 1, Ghrelin, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.